SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-025723
Filing Date
2021-05-10
Accepted
2021-05-10 06:05:43
Documents
64
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cnst-10q_20210331.htm   iXBRL 10-Q 2164941
2 EX-31.1 cnst-ex311_8.htm EX-31.1 17335
3 EX-31.2 cnst-ex312_7.htm EX-31.2 18172
4 EX-32.1 cnst-ex321_6.htm EX-32.1 7241
5 EX-32.2 cnst-ex322_9.htm EX-32.2 7321
  Complete submission text file 0001564590-21-025723.txt   6825135

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cnst-20210331.xsd EX-101.SCH 40573
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cnst-20210331_cal.xml EX-101.CAL 34251
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnst-20210331_def.xml EX-101.DEF 123820
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnst-20210331_lab.xml EX-101.LAB 324782
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnst-20210331_pre.xml EX-101.PRE 243943
11 EXTRACTED XBRL INSTANCE DOCUMENT cnst-10q_20210331_htm.xml XML 1211431
Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Filer) CIK: 0001434418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38584 | Film No.: 21905093
SIC: 2834 Pharmaceutical Preparations